Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-06

Clinical Trial Update: Tolcapone Treatment of Pathological Gambling [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tolcapone for pathological gambling has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolcapone (tolcapone)

Snippet

Sponsor: University of Chicago | Conditions: Pathological Gambling | Phase 2 | Status: COMPLETED | Results posted: 2014-03-06